5PSQ-031 Clinical and economic impact after breaking the single tablet abacavir/lamivudine/dolutegravir combo treatment into two drug regimens
Perez Puente, P, Barriga Rodríguez, P, Garrido Ameigeiras, MR, Caba Hernández, C, Tena Alejandre, P, Duque Aguilar, JJ, Sanchez Ferrer, J, Arnaiz Diez, S, Fernández Lisón, LC
Published in European journal of hospital pharmacy. Science and practice (01.03.2020)
Published in European journal of hospital pharmacy. Science and practice (01.03.2020)
Get full text
Journal Article